Alimentary Pharmacology & Therapeutics

Review article: the treatment of refractory Helicobacter pylori infection
pp. 1333-1343(11)
Authors: Mégraud, F.; Lamouliatte, H.

Review article: clinic-based testing for Helicobacter pylori infection by enzyme immunoassay of faeces, urine and saliva
pp. 1345-1354(10)
Author: Kabir, S.

Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial
pp. 1355-1364(10)
Authors: Sandborn, W. J.; Sands, B. E.; Wolf, D. C.; Valentine, J. F.; Safdi, M.; Katz, S.; Isaacs, K. L.; Wruble, L. D.; Katz, J.; Present, D. H.; Loftus, E. V.; Graeme-Cook, F.; Odenheimer, D. J.; Hanauer, S. B.

Mycophenolate mofetil in refractory inflammatory bowel disease
pp. 1365-1369(5)
Authors: Ford, A. C.; Towler, R. J.; Moayyedi, P; Chalmers, D. M.; Axon, A. T. R.

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia
pp. 1371-1380(10)
Authors: Reinisch, W.; Miehsler, W.; Dejaco, C.; Harrer, M.; Waldhoer, T.; Lichtenberger, C.; Vogelsang, H.

One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection
pp. 1381-1387(7)
Authors: Veldhuyzen Van Zanten, S.; Machado, S.; Lee, J.

Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points
pp. 1389-1397(9)
Authors: Kalantar, J. S.; Locke, G. R.; Talley, N. J.; Zinsmeister, A. R.; Fett, S. L.; Melton, L. J.

Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole
pp. 1399-1406(8)
Authors: Pilotto, A.; Leandro, G.; Franceschi, M.

A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population
pp. 1407-1413(7)
Authors: Wong, W. M.; Lam, K. F.; Lai, K. C.; Hui, W. M.; Hu, W. H. C.; Lam, C. L. K.; Wong, N. Y. H.; Xia, H. H. X.; Huang, J. Q.; Chan, A. O. O.; Lam, S. K.; Wong, B. C. Y.

Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies
pp. 1415-1423(9)
Authors: Tesei, N.; Sugai, E.; Vázquez, H.; Smecuol, E.; Niveloni, S.; Mazure, R.; Moreno, M. L.; Gomez, J. C.; Mauriño, E.; Bai, J. C.

Serotonergic modulators in the treatment of irritable bowel syndrome: influence on psychiatric and gastrointestinal symptoms
pp. 1425-1425(1)
Authors: Castle, M. Z. D.; Silk, D. B. A.; Libby, G. W.